Economic Assessment of the Secondary Prevention of Ischaemic Stroke with Dipyridamole plus Aspirin (Aggrenox ® /Asasantin ® ) in France

Author： Jean-Pierre Marissal   Bernard Selke  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.10, 2004-01, pp. : 661-670

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspirin plus dipyridamole effective in secondary stroke prevention

By  

Inpharma, Vol. 1, Iss. 1539, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Dipyridamole plus aspirin cost effective in stroke prevention

By  

Inpharma, Vol. 1, Iss. 1450, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Aspirin + dipyridamole preferable for stroke prevention

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Economic Assessment of the Secondary Prevention of Ischaemic Events with Lysine Acetylsalicylate

By Marissal J-P.   Selke B.   Lebrun T.  

PharmacoEconomics, Vol. 18, Iss. 2, 2000-08 ,pp. : 185-200

Adis International

Access to resources Recommend Favorite

Warfarin: no benefit over aspirin in ischaemic stroke prevention

By  

Inpharma, Vol. 1, Iss. 1315, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite